1. Home
  2. ARDX vs FFC Comparison

ARDX vs FFC Comparison

Compare ARDX & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.02

Market Cap

797.8M

Sector

Health Care

ML Signal

N/A

Logo Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

FFC

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

N/A

Current Price

$14.77

Market Cap

692.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ARDX
FFC
Founded
2007
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
797.8M
692.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
FFC
Price
$3.02
$14.77
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $12.80
N/A
AVG Volume (30 Days)
★ 4.3M
245.4K
Earning Date
11-03-2026
01-01-0001
Dividend Yield
N/A
★ 6.79%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,607,000.00
N/A
Revenue This Year
$19.21
N/A
Revenue Next Year
$28.19
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$14.26
52 Week High
$8.40
$16.95

Technical Indicators

Market Signals
Indicator
ARDX
FFC
Relative Strength Index (RSI) 37.18 48.72
Support Level N/A $14.32
Resistance Level $3.35 $16.34
Average True Range (ATR) 0.13 0.19
MACD 0.01 0.07
Stochastic Oscillator 15.19 79.83

Price Performance

Historical Comparison
ARDX
FFC

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.

Share on Social Networks: